Given the rise in GLP-1 medication use for diabetes management, understanding how these drugs could impact your teeth, gums, and mouth is huge
Qi L, Gao R, Chen Z, Lin D, Liu Z, Wang L, et al
This requires greater end-to-end visibility across the supply network so stakeholders can understand how demand changes work their way back up the chain from healthcare providers at the sharp end through to delivery performance and production
The current landscape for diabetes treatment: preventing diabetes-associated CV risk
Do not allow working stock to age beyond the stability window
Tissue-to-plasma concordance is incompletely defined, and many animal studies use young male mice with single-stressor models